Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04632264 · ClinicalTrials.gov registry record · NA
Postpartum Oxytocin Administration in the Era of Delayed Cord Clamping
A NA study of Postpartum Hemorrhage, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 104
- Enrollment target
- 1
- Study location
NCT04632264 is a NA study of Postpartum Hemorrhage that has completed, run by Columbia University. The registered enrollment target is 104 participants, below the 195-participant average among 11 other Postpartum Hemorrhage trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04632264, a NA study of Postpartum Hemorrhage, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
- 1
- Study location
Study Summary
Increased blood loss after vaginal or cesarean delivery is one of the top causes of maternal complications. Oxytocin is a common medication given to mothers by IV or an injection to limit the amount of blood loss after delivery. The investigators do not know the best time after delivery that oxytocin should be given. This research is being done to find out if starting the medication oxytocin right after the baby is born or after the placenta comes out decreases the amount of blood lost after birth when we delay cord clamping after birth.
Conditions Studied
Interventions
- OTHER Saline Placebo
- OTHER Initiation of standard postpartum oxytocin immediately following fetal shoulder delivery
- OTHER Initiation of standard postpartum oxytocin immediately following placenta delivery
Study Locations (1)
New York
- Columbia University Irving Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2020-12-10 |
| Est. Completion | 2021-09-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04632264
The ClinicalTrials.gov registry entry for NCT04632264 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 195-participant average among 11 other Postpartum Hemorrhage trials with a reported enrollment target (47% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Postpartum Hemorrhage appearing as the primary indexed condition, and to 3 interventions - of which Saline Placebo is the first listed.
NCT04632264 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04632264 about?
NCT04632264 is a clinical study titled "Postpartum Oxytocin Administration in the Era of Delayed Cord Clamping". Increased blood loss after vaginal or cesarean delivery is one of the top causes of maternal complications. Oxytocin is a common medication given to mothers by IV or an injection to limit the amount of blood loss after delivery. The investigators do not know the best time after delivery that oxytoci...
What is the current status of trial NCT04632264?
This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2020-12-10. Estimated completion is 2021-09-16.
What conditions does trial NCT04632264 study?
This clinical trial studies the following conditions: Postpartum Hemorrhage.
What interventions are being tested in trial NCT04632264?
The interventions under investigation include: Saline Placebo (OTHER), Initiation of standard postpartum oxytocin immediately following fetal shoulder delivery (OTHER), Initiation of standard postpartum oxytocin immediately following placenta delivery (OTHER).
Who is sponsoring clinical trial NCT04632264?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04632264 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postpartum Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Effectiveness of the KOKO Device to Treat Primary Abnormal Postpartum Uterine Bleeding or Hemorrhage
RECRUITING · NA
-
Active Versus Expectant Management of the Third Stage of Labor
COMPLETED · NA
-
Implementation of the NPMS Obstetric Hemorrhage Bundle at a Tertiary Center: Utilization of the Delphi Method
COMPLETED · NA
-
Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage
COMPLETED · NA
-
Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage
RECRUITING · Phase 3
-
Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.